In Vitro Diagnostics: Innovation and Integration
Executive Summary
Integration is occuring at almost every level of the in vitro diagnostic industry--at the preclinical level to decrease drug development costs and timelines and at the clinical level to better manage diseases. In the lab, there's a demand for new tools to improve speed and efficiency, and new information systems to better integrate disparate data. At the same time, there has been a flurry of integration and consolidation at the market level, with 35 mergers and acquisitions in the last 12 months.
You may also be interested in...
Integrated Diagnostics and Personalized Care: An Interview With GE Healthcare
To capitalize on the rapidly growing personalized medicine space, large imaging companies have been diversifying and acquiring in companies with molecular diagnostic product lines and pipelines. Medtech Insight recently spoke with two executives from GE Healthcare: Joe Camaratta, general manager, GE Healthcare's Category Solutions and Marketing Group; and Robert Dann, oncology strategic marketing leader, GE Healthcare's Medical Diagnostics Division, who provided some details on the company's overall strategy for personalized medicine and what these developments might mean for the future of patient care.
Integrated Diagnostics and Personalized Care: An Interview With GE Healthcare
To capitalize on the rapidly growing personalized medicine space, large imaging companies have been diversifying and acquiring in companies with molecular diagnostic product lines and pipelines. Medtech Insight recently spoke with two executives from GE Healthcare: Joe Camaratta, general manager, GE Healthcare's Category Solutions and Marketing Group; and Robert Dann, oncology strategic marketing leader, GE Healthcare's Medical Diagnostics Division, who provided some details on the company's overall strategy for personalized medicine and what these developments might mean for the future of patient care.
In Vitro Diagnostics: The Quest For Growth
This article first appeared in Medtech Insight, October 2010.